Genèse Labs

29

Participation in Dubai Derma 2026 — Dual Debut of MESO PEPTA™ and SofistiCa

Two new launches and our busiest booth yet at the Middle East’s largest dermatology congress Dubai, UAE — 8–10 September 2026 — Genèse Labs returned to Dubai Derma at the Dubai World Trade Centre for a second consecutive year, unveiling the peptide meso line MESO PEPTA™ and the CaHA filler SofistiCa for the first time. For three days, the booth was packed with visitors from across the Middle East, Africa and Sou..

2026-09-11

28

Participation in IMCAS China 2026 — Debut of Aqua Feel

Unveiling Aqua Feel in Shanghai, at the heart of the glass-skin trend Shanghai, China — 26–29 August 2026 — Genèse Labs took part in IMCAS China 2026 in Shanghai, taking its first formal step into China’s aesthetic-medicine market and unveiling its new hydro-rejuvenation complex, Aqua Feel, for the first time. Over four days, the booth was thronged with local practitioners and distribution partners.• First participation i..

2026-08-31

27

Participation in AMWC Korea 2026

Deepening scientific exchange with Korean practitioners — three months after launch Seoul, Korea — 19–20 June 2026 — Genèse Labs took part in AMWC Korea 2026 in Seoul, presenting its full portfolio — including NADX³ and AxeniQ™, launched in March — to Korea’s aesthetic-medicine specialists. Over both days, the booth was consistently crowded with practitioners seeking consultations.• Participation in the Korean e..

2026-06-22

26

Participation in AMWC Monaco 2026 — Global Launch of NADX³ and AxeniQ™

Bringing the 2026 launches to the world stage at the leading aesthetic and anti-ageing congress Monte-Carlo, Monaco — 26–28 March 2026 — Genèse Labs returned to AMWC at the Grimaldi Forum for a second consecutive year, successfully staging the global launch of NADX³ and AxeniQ™. For three days, the booth was crowded with practitioners and distribution partners from around the world.• Second consecutive participa..

2026-03-30

25

Participation in KIMES 2026 — Korean Debut of NADX³ and AxeniQ™

Unveiling the 2026 launches first at Korea’s largest medical exhibition Seoul, Korea — 19–22 March 2026 — Genèse Labs took part in the 41st Korea International Medical & Hospital Equipment Show (KIMES 2026) at COEX, unveiling its first launches of 2026 — the NAD⁺ skin booster NADX³ and the botulinum toxin AxeniQ™ — for the first time in Korea. Over four days, the booth was busy from opening to close with pra..

2026-03-23

24

Participation in i-SWAM 2025

Closing the year at one of Asia-Pacific’s leading aesthetic medicine congresses Tangerang, Indonesia — 5–7 December 2025 — Genèse Labs took part in the 16th International Seminar and Workshop in Aesthetic Medicine (i-SWAM) at ICE BSD, closing its 2025 international congress programme.• Participation in Indonesia’s largest aesthetic medicine congress and exhibition• Almost 300 international experts across aestheti..

2025-12-08

23

Exo-Mask Sheet Launch

A rose exosome bio-cellulose sheet mask designed for post-treatment recovery Paris, France — 17 November 2025 — Genèse Labs has launched Exo-Mask, a post-treatment sheet mask formulated with rose stem-cell exosomes and salmon DNA (PDRN), extending its portfolio from treatment through to aftercare.• Formulated with rose stem-cell exosomes, 1% salmon DNA (PDRN), NAD⁺, glutathione and hyaluronic acid• Bio-cellular sheet with..

2025-11-17

22

Participation in AMWC Latin America 2025

A second year in Medellín — deepening partnerships across Latin America Medellín, Colombia — 16–18 October 2025 — Genèse Labs returned to AMWC Latin America for a second consecutive year at Plaza Mayor Medellín, strengthening its relationships with practitioners and distribution partners across the region.• Second consecutive participation in AMWC Latin America, following 2024• First Latin American presentation ..

2025-10-21

21

Participation in InterCHARM Moscow 2025

Meeting a new regional market at the largest beauty exhibition in Russia and the CIS Moscow, Russia — 15–18 October 2025 — Genèse Labs took part in InterCHARM 2025 at Crocus Expo, presenting its portfolio to cosmetology and aesthetic-medicine professionals from Russia and the CIS region.• Participation in the largest beauty exhibition in Russia, Eastern Europe and Central Asia• More than 1,600 companies from Rus..

2025-10-20

20

Proluma™ RH Collagen Launch

A skin booster built on recombinant human collagen Type I and III Paris, France — 8 September 2025 — Genèse Labs has launched Proluma™ RH Collagen, a skin booster built on recombinant human collagen Type I and III, extending the Proluma™ brand beyond biostimulators into collagen-based skin quality.• Recombinant human collagen Type I and III produced through bio-fermentation technology• Animal-free ingredient rep..

2025-09-08

19

Participation in Vietbeauty 2025

Presenting the regenerative skincare portfolio in Vietnam’s fast-growing beauty market Ho Chi Minh City, Vietnam — 24–26 July 2025 — Genèse Labs took part in Vietbeauty & Cosmobeauté Vietnam 2025 at the Saigon Exhibition and Convention Center (SECC), broadening its reach into Vietnam’s beauty and aesthetic-medicine market.• Participation in Vietnam’s leading international beauty trade exhibition• A B2B-focus..

2025-07-27

18

Exoluma™ Exo-PDRN Launch

Dual regeneration technology: French salmon DNA-derived PDRN meets plant-derived exosomes Paris, France — 16 June 2025 — Genèse Labs has launched Exoluma™ Exo-PDRN, a skin booster combining salmon sperm DNA-derived PDRN with plant-derived exosomes, extending the exosome-based Exoluma™ platform.• Pharmaceutical-grade salmon DNA-derived PDRN manufactured in France by HTL Biotechnology• Dual-regeneration concept: P..

2025-06-16

검색

We value your privacy